Donor-specific antibodies in vascularized composite allotransplantation: A multicenter study.
Vascularized Composite Allotransplantation (VCA) requires immunosuppression to prevent allosensitization and subsequent allograft rejection. This study evaluated the prevalence, characteristics, and clinical implications of donor-specific antibodies (DSA) in VCA recipients. Thirty-seven VCA recipients (median age 32.5 ...